Recently, PANTHERx Rare’s CEO, Bansi Nagji, was honored to participate in an expert panel moderated by Eric Percher titled, “Next-Gen Hub & Pharmacy: New Approaches to Specialty & Direct-to-Patient,” at Nephron Research LLC’s Pharmacy & PBM Innovation Symposium on July 10. Bansi, alongside industry leaders Alicia Boler Davis of Alto Pharmacy and Sarah Thomas of HealthDyne, discussed a range of pharmacy models, how they’re evolving, and the value they can bring in improving personalization, care delivery, and health outcomes. Bansi also detailed the key differences between traditional specialty pharmacies and those—like PANTHERx Rare Pharmacy—that exclusively serve people living with rare and devastating conditions. Thank you, Bansi, for sharing your perspective and insights on these important issues! #NephronResearch #SpecialtyPharmacy #RareDisease #PatientAccess #PANTHERxRare
What an incredible showing at last week's 2025 Nephron Pharmacy & PBM Innovation Symposium! 🙌 Huge thanks to our outstanding panelists who delivered actionable insights on the regulatory shifts and profit pool transformations reshaping our industry. Already looking forward to next year! For those who missed it, register at link below for an invite in 2026. https://xmrrwallet.com/cmx.plnkd.in/e-jpcQy3 #Nephron2025 #PBM #HealthcarePolicy #PharmacyInnovation
Operating Advisor Nautic Partners LLC, Chairman of the Board and Board Advisor.
4wThank you Eric Percher for hosting such relevant and important topics in Specialty and Rare Disease. Bansi Nagji has done a masterful job in re-configuring PANTHERx Rare Pharmacy to be the premier pharmacy operating model in rare and orphan disease states. Level Up everyone.